Saturday, March 22, 2025

Creating liberating content

BJP MLAs are evicted by marshals on Friday after their

MUMBAI: The rupee on Friday regained 85 level, posting its

Related News

BJP MLAs are evicted by marshals on Friday after their suspension for ‘disrespecting the Chair’ while demanding a probe into honey-trap cases BENGALURU: Both Houses of Karnataka legislature Friday passed

This is a representational AI image A New Jersey man is suing United Airlines, alleging that a pilot forcibly removed him from an aeroplane bathroom mid-flight while his pants were

Nearly half of the Indians deported from the US in five commercial flights from Panama from Feb 20 to March 2 belonged to Punjab, according to Union junior minister for

MUMBAI: The rupee on Friday regained 85 level, posting its strongest gain against the dollar in over a month, supported by foreign fund inflows and the unwinding of speculative long-dollar

MUMBAI: IndusInd Bank‘s board has decided to appoint an external agency to conduct a comprehensive investigation into discrepancies identified in its derivative portfolio.On March 10, the bank disclosed that there

NEW DELHI: Boeing has laid off up to 180 employees at its Boeing India Engineering Technology Center (BIETC) in Bengaluru as part of a global downsizing exercise. Boeing senior VP

Trending News

MUMBAI: The rupee on Friday regained 85 level, posting its strongest gain against the dollar in over a month, supported by foreign fund inflows and the unwinding of speculative long-dollar

MUMBAI: IndusInd Bank‘s board has decided to appoint an external agency to conduct a comprehensive investigation into discrepancies identified in its derivative portfolio.On March 10, the bank disclosed that there

MUMBAI: Mukesh Ambani-led Reliance Industries is set to acquire 74% of Nauyaan Shipyard from Welspun Corp, owned by B K Goenka, for Rs 383 crore, gaining access to 138 acres

MUMBAI: L&T plans to raise Rs 12,000 crore through debt instruments for its financial requirements while announcing organisational modifications at the $27-billion company. It will explore non-convertible debentures, external commercial

March 2025 bank holidays: With the financial year drawing to a close, people and businesses typically hasten to finalise their banking activities, including tax submissions, investment decisions and monetary settlements.

CLSA has a ‘hold’ recommendation on Voltas with a target price of Rs 1,375. Analysts said that the company indicated encouraging secondary sales ahead of peak summer season on a

‘Once-A-Week Shot’ Weight-Loss Drug Mounjaro Launched In India By Eli Lilly

Word Count: 337 | Estimated Reading Time: 2 minutes




New Delhi:

Eli Lilly and Company (India) on Thursday said it has launched a first-of-its-kind medication for obesity and type 2 diabetes in the country after obtaining approval from the Central Drugs Standard Control Organisation (CDSCO).

The company said it has introduced Mounjaro in a single-dose vial presentation following the marketing authorisation from the CDSCO.

It is a first-of-its-kind treatment for obesity, overweight, and type 2 diabetes that activates both GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) hormone receptors.

Mounjaro is indicated as an adjunct to a reduced-calorie diet and increased physical activity for chronic weight management in adults with an initial body mass index (BMI) of 30 kg/m2 or greater (obesity) or 27 kg/m2 or greater (overweight) in the presence of at least one weight-related comorbid condition.

It is also indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.

“The dual burden of obesity and type 2 diabetes is rapidly emerging as a major public health challenge in India. Lilly is committed to collaborating with the government and industry to promote awareness and improve the prevention and management of these diseases,” Eli Lilly India President and General Manager Winselow Tucker said.

The company’s mission is to make life better for people living with obesity and diabetes in India, he added.

India has about 101 million people living with diabetes and nearly half of these in the adult patients category are being inadequately treated with suboptimal glycemic control.

Obesity, a chronic relapsing disease, is a major risk factor for diabetes and is linked to over 200 health complications, including hypertension, dyslipidemia, coronary heart disease, and obstructive sleep apnea.

As of 2023, adult obesity prevalence in India stood at around 6.5 per cent, affecting nearly 100 million people.

Once-a-weekly, prescription-based medicine, Mounjaro is a single molecule that selectively binds to and activates both GIP and GLP-1 receptors, which are natural incretin hormones.

(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)




Source link

Most Popular Articles